Gynecologic Cancers in Pregnancy Guidelines of a Second International Consensus Meeting
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F14%3A10292775" target="_blank" >RIV/00064203:_____/14:10292775 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11130/14:10292775
Výsledek na webu
<a href="http://dx.doi.org/10.1097/IGC.0000000000000062" target="_blank" >http://dx.doi.org/10.1097/IGC.0000000000000062</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/IGC.0000000000000062" target="_blank" >10.1097/IGC.0000000000000062</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Gynecologic Cancers in Pregnancy Guidelines of a Second International Consensus Meeting
Popis výsledku v původním jazyce
Objectives This study aimed to provide timely and effective guidance for pregnant women and health care providers to optimize maternal treatment and fetal protection and to promote effective management of the mother, fetus, and neonate when administeringpotentially teratogenic medications. New insights and more experience were gained since the first consensus meeting 5 years ago. Methods Members of the European Society of Gynecological Oncology task force Cancer in Pregnancy in concert with other international experts reviewed the existing literature on their respective areas of expertise. The summaries were subsequently merged into a complete article that served as a basis for discussion during the consensus meeting. All participants approved the final article. Results In the experts' view, cancer can be successfully treated during pregnancy in collaboration with a multidisciplinary team, optimizing maternal treatment while considering fetal safety. To maximize the maternal outcome,
Název v anglickém jazyce
Gynecologic Cancers in Pregnancy Guidelines of a Second International Consensus Meeting
Popis výsledku anglicky
Objectives This study aimed to provide timely and effective guidance for pregnant women and health care providers to optimize maternal treatment and fetal protection and to promote effective management of the mother, fetus, and neonate when administeringpotentially teratogenic medications. New insights and more experience were gained since the first consensus meeting 5 years ago. Methods Members of the European Society of Gynecological Oncology task force Cancer in Pregnancy in concert with other international experts reviewed the existing literature on their respective areas of expertise. The summaries were subsequently merged into a complete article that served as a basis for discussion during the consensus meeting. All participants approved the final article. Results In the experts' view, cancer can be successfully treated during pregnancy in collaboration with a multidisciplinary team, optimizing maternal treatment while considering fetal safety. To maximize the maternal outcome,
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
International Journal of Gynecological Cancer
ISSN
1048-891X
e-ISSN
—
Svazek periodika
24
Číslo periodika v rámci svazku
3
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
10
Strana od-do
394-403
Kód UT WoS článku
000332519000005
EID výsledku v databázi Scopus
—